Aegerion Pharmaceuticals: Berman Tabacco Announces Client Recovery in $6.5 Million Self-Litigated False Claims Act Settlement Involving Eight Former Executives and Employees of Aegerion Pharmaceuticals, Inc.
BOSTON, MA / ACCESSWIRE / December 20, 2019 / Berman Tabacco announces a $6.5 million settlement in a False Claims Act case brought against eight former executives and employees of Aegerion Pharmac...
Read full article »
CEO
Aegerion is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of severe and rare diseases.
Read more